CC
Schedule 13G filing
Coastlands Capital LP disclosed a 5.4% stake in Pyxis Oncology, Inc. (PYXS)
Coastlands Capital LP reported owning 5.4% of Pyxis Oncology, Inc. (PYXS) (6,448,907 shares) in a Schedule 13G filed Oct 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More PYXS insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.